Explore 3 Stock Ideas & Industry Insights Download Free Report

Beyond Medical Technologies Inc

Industrials US DOCKF

0.1379USD
0.00(0%)

Last update at 2026-06-19T20:00:00Z

Day Range

0.030.03
LowHigh

52 Week Range

0.050.53
LowHigh

Fundamentals

  • Previous Close 0.14
  • Market Cap2.31M
  • Volume20
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.77319M
  • Revenue TTM-0.02194M
  • Revenue Per Share TTM-0.003
  • Gross Profit TTM -0.25049M
  • Diluted EPS TTM-0.07

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -0.36588M -0.55200M -0.83511M -2.91276M -6.52093M
Minority interest - - - - -
Net income -0.28594M -0.59596M -1.40085M -2.91276M -6.52093M
Selling general administrative 0.11M 0.19M 0.84M 1.62M 1.91M
Selling and marketing expenses - - - - -
Gross profit - - - -0.25049M 0.02M
Reconciled depreciation - - - 0.17M 0.14M
Ebit - - - -2.07651M -2.00405M
Ebitda - - -0.83692M -2.72543M -1.93282M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -0.43899M -0.54847M -0.83692M -2.06428M -2.07518M
Other operating expenses - - - - -
Interest expense - - - 0.01M 0.00000M
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - -0.01424M 0.00705M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 0.00000M 0.00000M 0.00000M 0.94M 0.21M
Total operating expenses 0.44M 0.55M 0.84M 3.01M 2.28M
Cost of revenue - - - 1.19M 0.18M
Total other income expense net 0.07M -0.00353M 0.00181M -0.83423M -4.45280M
Discontinued operations - - - - -
Net income from continuing ops -0.36588M -0.55200M -0.83511M -2.91276M -6.52093M
Net income applicable to common shares - - - -2.91276M -6.52093M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 0.01M 0.10M 0.61M 1.95M 1.84M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - - - 0.00129M 0.03M
Total liab 0.63M 0.43M 0.35M 0.41M 0.36M
Total stockholder equity -0.62066M -0.33472M 0.26M 1.54M 1.48M
Deferred long term liab - - - - -
Other current liab - 0.09M 0.09M 0.15M 0.01000M
Common stock - - - 23.58M 20.78M
Capital stock 23.58M 23.58M 23.58M 23.58M 20.78M
Retained earnings -26.38415M -26.09821M -25.62161M -25.25365M -22.34089M
Other liab - - - - -
Good will - - - - -
Other assets - - - 0.03M 0.04M
Cash 0.01M 0.06M 0.54M 1.43M 0.62M
Cash and equivalents - - - - -
Total current liabilities 0.63M 0.43M 0.35M 0.41M 0.27M
Current deferred revenue - - - - -
Net debt 0.05M - - - -
Short term debt - - - - -
Short long term debt 0.06M 0.03M - - -
Short long term debt total - - - - -
Other stockholder equity - - - 3.22M 3.04M
Property plant equipment - - - 0.11M 0.61M
Total current assets 0.01M 0.10M 0.58M 1.81M 1.19M
Long term investments - - - - -
Net tangible assets - - - 1.54M 1.48M
Short term investments - - - - -
Net receivables - - 0.00000M 0.03M 0.10M
Long term debt - - - - -
Inventory - - 0.00000M 0.32M 0.37M
Accounts payable 0.10M 0.10M 0.13M 0.17M 0.19M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - 0.03M 0.03M
Deferred long term asset charges - - - - -
Non current assets total 0.00000M 0.00000M 0.03M 0.14M 0.65M
Capital lease obligations - - 0.00000M 0.09M 0.17M
Long term debt total - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments - - 0.00000M -0.46799M 0.26M
Change to liabilities - - - -0.01228M 0.09M
Total cashflows from investing activities - - - -0.46799M -0.26027M
Net borrowings 0.03M 0.03M - -0.07992M -0.06596M
Total cash from financing activities 0.03M 0.03M 0.00000M 2.67M -0.06596M
Change to operating activities - - - 0.20M 0.14M
Net income -0.28594M -0.59596M -1.40085M -2.91276M -6.52093M
Change in cash -0.07977M -0.49704M -0.89401M 0.81M -2.16032M
Begin period cash flow 0.06M 0.54M 1.43M 0.62M 2.78M
End period cash flow 0.01M 0.06M 0.54M 1.43M 0.62M
Total cash from operating activities -0.10977M -0.52704M -0.89401M -1.39905M -1.83404M
Issuance of capital stock - - 0.00000M 2.70M -
Depreciation - - - 0.17M 0.14M
Other cashflows from investing activities - - - -0.40000M 0.02M
Dividends paid - - - - -
Change to inventory - - - 0.05M -0.18843M
Change to account receivables - - - 0.03M 0.04M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - -0.07318M -0.07318M
Change to netincome - - - 1.05M 4.46M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.07M 0.23M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.33M 0.05M 0.09M 0.29M 0.08M
Stock based compensation - 0.00000M 0.12M 0.20M 0.00707M
Other non cash items - - - 0.41M 4.24M
Free cash flow -0.10977M -0.52704M -0.89401M -1.46703M -2.06815M

Peer Comparison

Sector: Industrials Industry: Pollution & Treatment Controls

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
DOCKF
Beyond Medical Technologies Inc
- -% 0.14 - - 1.41 1.99 0.34 0.04
VLTO
Veralto Corporation
-1.07 1.27% 82.95 29.06 27.70 4.78 10.95 5.04 20.26
FSS
Federal Signal Corporation
-1.08 0.91% 117.44 28.73 24.21 3.17 5.00 3.41 17.76
UMICY
Umicore SA ADR
-0.52 7.69% 6.24 12.18 13.89 0.29 1.66 0.36 8.26
UMICF
Umicore SA
- -% 28.40 12.12 13.66 0.29 1.64 0.36 8.28

Reports Covered

Stock Research & News

Profile

Republic Technologies Inc. provides decentralized global computing platform that enable smart contracts, tokenized assets, and financial settlements. The company operates validator infrastructure to support network security and consensus generating protocol rewards. It serves healthcare, regulatory compliance, supply chain management, financial services, education, and other sectors. The company was formerly known as Beyond Medical Technologies Inc. and changed its name to Republic Technologies Inc. in July 2025. Republic Technologies Inc. is headquartered in Vancouver, Canada.

Beyond Medical Technologies Inc

1111 West Hastings Street, Vancouver, BC, Canada, V6E 2J3

Key Executives

Name Title Year Born
Mr. Kulwant Sing Malhi Chairman & CEO 1967
Mr. Harveer Singh Sidhu Pres & Director NA
Ms. Zahara Kanji-Aquino CPA, CGA, CPA Chief Financial Officer 1971
Ms. Karen Lauriston VP of Corp. Communications & Investor, Community and Gov. Relations NA
Mr. Daniel Liu CEO & Director NA
Mr. Stevenson Ty Interim Chief Financial Officer NA
Ms. Litong Cao COO & Director NA
Ms. Karen Lauriston Vice President of Corporate Communications & Investor, Community and Government Relations NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.